Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib plus carboplatin and paclitaxel in ovarian and breast cancer
NCT00316407Phase 2Completed
- Sponsor
- Swedish Health Services
- Start
- Aug 2005
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in ovarian epithelial cancer, breast cancer, fallopian tube carcinoma (PFTC), primary peritoneal carcinoma (PPC), sponsored by Swedish Health Services. Started Aug 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
ovarian epithelial cancerbreast cancerfallopian tube carcinoma (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00316407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316407.